• UBR5–TERT Control of Vascular Organoid Stress

  2026-09-22

  Zhao et al. identify the E3 ligase UBR5 as a regulator of TERT stability in human vascular models exposed to oxidative stress. Their results connect UBR5-dependent protein turnover with endothelial progenitor cell function, vascular organoid development, and senescence, suggesting a mechanistic route for protecting vascular tissue under pathological redox conditions.

• Native-Membrane Proteoforms and Drug Selectivity

  2026-09-22

  The reference study establishes a native-membrane mass spectrometry strategy for connecting protein modifications with ligand binding and complex assembly. Its rhodopsin, G-protein, and PDE6 results show how proteoform state can influence off-target drug recognition in ways that conventional cell assays and bottom-up proteomics may not resolve.

• CGP 55845 Hydrochloride: GABAB Antagonist

  2026-09-21

  CGP 55845 hydrochloride is a selective GABAB receptor antagonist used to separate receptor-dependent signaling from transporter-mediated effects in cellular and electrophysiological models. Its reported affinity, baclofen antagonism, and neurotransmitter-release effects support controlled in vitro neurotransmission assays, but no in vivo or clinical studies of the compound are reported.

• GhATL68b Links Ubiquitination to Cotton Fiber Growth

  2026-09-21

  A 2024 Plant Communications study identifies the RING-type E3 ligase GhATL68b as a regulator of cotton fiber development through ubiquitination of 2,4-dienoyl-CoA reductase, an enzyme involved in polyunsaturated fatty-acid β-oxidation. Genetic, biochemical, and metabolic-rescue experiments connect this pathway to fiber quality, membrane lipid composition, and cell elongation, offering a mechanistic framework for studying proteostasis in plant development.

• MLN2238: Proteasome β5 Inhibitor Workflows

  2026-09-20

  MLN2238 enables β5-focused proteasome inhibition for mechanistic studies in multiple myeloma, lymphoma, and drug-resistant cell models. This workflow connects biochemical potency with apoptosis, proteotoxic stress, and ROS–JNK–CREB signaling while addressing solubility, dosing, and assay-interpretation challenges.

• HyperScribe T7 High Yield RNA Synthesis Kit for OSCC

  2026-09-19

  Translate the LINC02613–LCP1 mechanism in oral squamous cell carcinoma into reproducible RNA pull-down, probe-generation, and RNA interference workflows. The HyperScribe™ platform combines high-yield T7 transcription with flexible labeling and modified-nucleotide options for mechanism-focused assays.

• NU6300 Targets GSDMD Cys191 to Block Pyroptosis

  2026-09-18

  Jiang et al. identify NU6300 as a covalent gasdermin D inhibitor that reacts with cysteine-191, blocking both GSDMD cleavage and the palmitoylation required for membrane pore formation. The study combines biochemical, cellular, and in vivo inflammation models to show that NU6300 suppresses pyroptosis and improves outcomes in experimental colitis and sepsis.

• CD40–STING–TRAF2 Signaling in ESCC TLS

  2026-09-18

  This study identifies tertiary lymphoid structures as favorable prognostic features in treatment-naïve esophageal squamous cell carcinoma and links them to activated, IRF4-positive B cells. Its mechanistic contribution is the discovery that CD40 and STING compete for TRAF2, coupling receptor signaling, STING ubiquitination and phosphorylation, and non-canonical NF-κB-dependent B-cell activation.

• H 89 2HCl: PKA Inhibition and cAMP Signaling

  2026-09-17

  H 89 2HCl is a biochemical tool for cAMP-dependent protein kinase inhibition and cellular studies of protein phosphorylation modulation. The compound inhibits PKA with a reported Ki of 48 nM, but its broader kinase activity requires concentration-aware controls and orthogonal validation.

• MLN2238: Mapping Proteasome Stress Responses

  2026-09-17

  MLN2238 is a selective proteasome β5 subunit inhibitor that can be used not only to study proteasome blockade, but also to map adaptive stress signaling. This article translates CRTC-CREB research into a decision framework for oncology, proteostasis, and resistance-focused assays.

• Cy5-UTP for Mechanistic RNA Imaging

  2026-09-16

  Cy5-UTP enables direct fluorescent RNA labeling for FISH, expression analysis, and RNA probe synthesis. This article explains how to use Cyanine 5-uridine triphosphate as an analytical tool for separating RNA production, probe performance, and nanoparticle-mediated delivery effects.

• Rapakinin Signaling in Hypertensive Rat Arteries

  2026-09-16

  The reference study identified rapakinin, an Arg-Ile-Tyr peptide from rapeseed protein, as an endothelium-dependent vasorelaxant in mesenteric arteries from spontaneously hypertensive rats. Pharmacological experiments placed prostaglandin I2 signaling through the IP receptor upstream of CCK1-receptor-dependent relaxation, distinguishing this pathway from the nitric oxide and bradykinin mechanisms commonly associated with ACE-related vasodilation.

• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-09-15

  Build a dual-readout workflow that separates mRNA uptake from productive protein expression using Cy5 fluorescence and Firefly Luciferase bioluminescence. This guide covers carrier optimization, assay controls, intracellular tracking, and troubleshooting for reproducible mRNA delivery studies.

• CCG-1423: Mechanism of a RhoA Inhibitor

  2026-09-15

  CCG-1423 is a RhoA inhibitor that blocks the MRTF-A/importin α/β1 nuclear-import interaction without disrupting MRTF-A binding to monomeric G-actin. Its documented research uses include cancer research, proliferation and invasion studies, and apoptosis assay design, while a separate 2025 study establishes RhoA/ROCK1/MLC2 signaling as a mechanism of tight-junction disruption during MVC infection.

• PYR-41 for E1 Inhibition in Cell Assays

  2026-09-14

  A scenario-based guide to using PYR-41, inhibitor of Ubiquitin-Activating Enzyme (E1), in cell viability, proliferation, cytotoxicity, and inflammatory signaling workflows. It explains how SKU B1492 can improve experimental interpretability through controlled solvent handling, evidence-linked concentration selection, and appropriate mechanistic controls.

8455 records 1/564 page Next 12345 下5页 Last page